Delivery Order SPE2DB22D3301-SPE2DB25FX8GK
Award Date
1/10/25
Potential Completion Date
2/3/25
Potential Value
$8.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $2,817.84 for the provision of VEKLURY 100 MG VIALS, a critical pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,886.60 Firm Fixed Price delivery order is for the procurement of VEKLURY 100 MG VIALS, a critical pharmaceutical product. The contract award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, which serves as a primary vehicle for...
The federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $13,618.40 Firm Fixed Price delivery order contract is for the supply of VEKLURY 100 MG vials, a critical pharmaceutical product. This award is a part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999, to provide a comprehensive range of medical commodities in...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $4,085.52 under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). The contract is for the supply of VEKLURY 100 MG VIALS, a critical pharmaceutical product, with an ultimate completion date of December 4, 2024. Amerisourcebergen, a for-profit organization registered in the System for Award Management (SAM.gov), has established...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,042.76 firm fixed-price delivery order is for the supply of VEKLURY 100 MG VIALS, with a performance period ending on February 14, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award, with ID SPE2DB22D3016|SPE2DB25FACN2, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,618.40 firm fixed-price delivery order is for the supply of VEKLURY 100 MG VIALS, a critical pharmaceutical product, with a period of performance through November 27, 2024. This contract award is not designated as a set-aside. The DLA, as the primary contracting agency,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $20,427.60 firm fixed-price delivery order is for the supply of VEKLURY 100 mg vials, a pharmaceutical product used to treat COVID-19. The contract has an ultimate completion date of August 2, 2024 and does not utilize a set-aside designation. Amerisourcebergen Drug Corp, a subsidiary of the major pharmaceutical distribution company...
This federal contract award is for the delivery of VEKLURY 100 MG VIAL pharmaceutical products to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $13,606.80 and an ultimate completion date of January 31, 2022. It is a Firm Fixed Price Delivery Order contract, with no set-aside designation. Amerisourcebergen Drug Corp is a subsidiary of the parent...
This federal contract award to Amerisourcebergen Drug Corp (Amerisourcebergen) is a delivery order (SPE2DB22D2211|SPE2DB25FRHYA) for the supply of VEKLURY 100 MG VIALS, valued at $2,042.76. The contract has a firm-fixed price and is set to be completed by November 20, 2024. Amerisourcebergen is a major pharmaceutical distributor and healthcare solutions provider registered in the System for Award Management (SAM.gov) since 2002. The contract is awarded by the Defense Logistics Agency (DLA), a...
This federal contract award, valued at $8,171.04, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The award is for the delivery of VEKLURY 100 MG VIALS, a pharmaceutical product, with a completion date of June 24, 2024. This is a firm fixed-price delivery order contract. Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, has a significant Indefinite Delivery...